Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME-Reference-Cited by-同舟云学术

Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME

Published:2024-04-04 Issue:4 Volume:14 Page:643-647
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:

Author:

Phan Tri Giang¹²^ORCID,Weilbaecher Katherine N.³^ORCID,Aft Rebecca⁴^ORCID,Croucher Peter I.¹²^ORCID,Chaffer Christine L.¹²⁵^ORCID

Affiliation:

1. 1Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.

2. 2St. Vincent's Healthcare Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Darlinghurst, New South Wales, Australia.

3. 3Department of Medicine and Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.

4. 4Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.

5. 5Kinghorn Cancer Center, Darlinghurst, New South Wales, Australia.

Abstract

Summary: Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.

Publisher

American Association for Cancer Research (AACR)

Link

https://aacrjournals.org/cancerdiscovery/article-pdf/14/4/643/3440900/643.pdf

Reference15 articles.

1. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study;Wilson;Lancet Oncol,2019

2. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010;Malmgren;Breast Cancer Res Treat,2018

3. Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry;Hölzel;J Cancer Res Clin Oncol,2017

4. Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the “ATRESS” phenomenon;Jurrius;Breast,2020

5. The dormant cancer cell life cycle;Phan;Nat Rev Cancer,2020